Patients entered into MRC AML trials are biologically representative of the totality of the disease in the UK
Source: Clinical & Laboratory Haematology, Volume 24, Number 4, August 2002 , pp. 263-265(3)
Publisher: Wiley-Blackwell
Document Type: Correspondence
DOI: http://dx.doi.org/10.1046/j.1365-2257.2002.00445.x
Publication date: 2002-08-01
- In this: publication
- By this: publisher
- In this Subject: Internal Medicine

Shopping cart
Receive new issue alert
Get Permissions